Adaptive Biotechnologies Statistics
NASDAQ: ADPTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
26.28-0.62 (-2.30%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Adaptive Biotechnologies by the numbers
Adaptive Biotechnologies has a market capitalization of $4.19 billion based on 159.60M shares outstanding. With trailing EPS of $-0.41, Adaptive Biotechnologies is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.7% above its 50-day average and 39.9% above its 200-day average.
Average daily trading volume is 2.39M shares, or about $62.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ADPT valuation vs. peer median
| Metric | ADPT | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.19B | $4.50B | -7% |
| Avg. volume | 2.39M | 1.58M | +51% |
Peer median across 8 companies: RLAY, TARS, CRSP, SRRK, DNLI, CGON, KOD, BEAM.
Valuation
- Market cap
- $4.19B
- Price / sales (latest FY)
- 15.14
- EPS (TTM)
- $-0.41
- Shares outstanding
- 159.60M
Price and trading
- Previous close
- 26.90
- Open
- 26.35
- Day range
- 25.87 – 26.93
- 52-week range
- 12.00 – 30.74
- 52-week change
- +83.14%
- Beta
- —
- Volume
- 2.12M
- Average volume
- 2.39M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 4.19B
- Forward Pe
- -145.64
- Eps
- -0.41
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 30.74
- Week52 Low
- 12.00
- Avg Volume
- 2.39M
- Shares Outstanding
- 159.60M
- Ma50
- 25.83
- Ma200
- 18.78
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -14.51%
- Pct From52w Low
- 119.00%